Warning letterFDA · Mar 20, 2017
Vacunda & Design 3/20/17
Named company: Vacunda & Design
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Sinai Cannabis Oil, Sinai Soursop Oil, and…
Lot information: not specified in this record.